The immunocompromised: Host HIV infection

Proceedings of the American Thoracic Society

Volumn 2, Issue 5, 2005, Pages 423-427

  Beck, James M ^a,b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alveolar; Hiv infections; Macrophages; Neutrophils; Opportunistic infections; T lymphocytes

Indexed keywords

TUMOR NECROSIS FACTOR;

ANTIGEN PRESENTATION; B LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL COUNT; CELL MEMBRANE; CONFERENCE PAPER; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LUNG ALVEOLUS CELL; LUNG INFECTION; LYMPHOCYTE FUNCTION; MACROPHAGE FUNCTION; NATURAL KILLER CELL; NEUTROPHIL; PHAGOCYTOSIS; PHENOTYPE; RESPIRATORY BURST;

EID: 31144468985     PISSN: 15463222     EISSN: 15463222     Source Type: Journal    
DOI: 10.1513/pats.200507-077js     Document Type: Conference Paper

References (50)

1. Beck JM, Rosen MJ, Peavy HH. Pulmonary complications of HIV infection: report of the fourth NHLBI workshop. Am J Respir Crit Care Med 2001;164:2120-2126.
2. Salahuddin SZ, Rose RM, Groopman JE, Markham PD, Gallo RC. Human T lymphotropic virus type III infection of human alveolar macrophages. Blood 1986;68:281-284.
3. Agostini C, Trentin L, Zambello R, Semenzato G. HIV-1 and the lung: infectivity, pathogenic mechanisms and cellular immune responses taking place in the lower respiratory tract. Am Rev Respir Dis 1993;147:1038-1049.
4. Rose RM, Krivine A, Pinkston P, Gillis JM, Huang A, Hammer SM. Frequent identification of HIV-1 DNA in bronchoalveolar lavage cells obtained from individuals with the acquired immunodeficiency syndrome. Am Rev Respir Dis 1991;143:850-854.
5. Sierra-Madero JG, Toossi Z, Hom DL, Finegan CK, Hoenig E, Rich EA. Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type 1-infected persons, production of cytokines, and clinical status. J Infect Dis 1994;169:18-27.
6. Lewin SR, Kirihara J, Sonza S, Irving L, Mills J, Crowe SM. HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals. AIDS 1998;12:719-727.
7. Wood KL, Chaiyarit P, Day RB, Wang Y, Schnizlein-Bick CT, Gregory RL, Twigg HL III. Measurements of HIV viral loads from different levels of the respiratory tract. Chest 2003;124:536-542.
8. Itescu S, Simonelli PF, Winchester RJ, Ginsberg HS. Human immunodeficiency virus type 1 strains in the lungs of infected individuals evolve independently from those in peripheral blood and are highly conserved in the C-terminal region of the envelope V3 loop. Proc Natl Acad Sci USA 1994;91:11378-11382.
9. Gates A, Coker RJ, Miller RF, Williamson JD, Clarke JR. Zidovudine-resistant variants of HIV-1 in the lung. AIDS 1997;11:702-703.
10. White NC, Israël-Biet D, Coker RJ, Mitchell DM, Weber JN, Clarke JR. Different resistance mutations can be detected simultaneously in the blood and the lung of HIV-1 infected individuals on antiretroviral therapy. J Med Virol 2004;72:325-357.
11. White NC, Agostini C, Israël-Biet D, Semenzato G, Clarke JR. The growth and the control of human immunodeficiency virus in the lung: implications for highly active antiretroviral therapy. Eur J Clin Invest 1999;29:964-972.
12. Fiala M, Herman V, Gornbein J. Role of CD8+ in late opportunistic infections of patients with AIDS. Res Immunol 1992;143:903-907.
13. Sheridan JF, Aurelian L, Donnenberg AD, Quinn TC. Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses. J Clin Immunol 1984;4:304-311.
14. Sereti I, Lane HC. Immunopathogenesis of human immunodeficiency virus: implications for immune-based therapies. Clin Infect Dis 2001;32:1738-1755.
15. Center DM, Kornfeld H, Ryan TC, Cruikshank WW. Interleukin 16: implications for CD4 functions and HIV-1 progression. Immunol Today 2000;21:273-280.
16. Murray HW, Hillman JK, Rubin BY, Kelly CD, Jacobs JL, Tyler LW, Donelly DM, Carriero SM, Godbold JH, Roberts RB. Patients at risk for AIDS-related opportunistic infections: clinical manifestations and impaired gamma interferon production. N Engl J Med 1985;313:1504-1510.
17. Clerici M, Lucey DR, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP, Dolan MJ, Hendrix CW, Wolf SF, Shearer GM. Restoration of HIV specific cell-mediated immune responses by interleukin-12 in vitro. Science 1993;262:1721-1724.
18. Semenzato G. Immunology of interstitial lung diseases: cellular events taking place in the lung of sarcoidosis, hypersensitivity pneumonitis and HIV infection. Eur Respir J 1991;4:94-102.
19. Shearer GM, Bernstein DC, Tung KSK, Via CS, Redfield R, Salahuddin SZ, Gallo RC. A model for the selective loss of major histocompatibility complex self-restricted T cell immune response during the development of acquired immune deficiency syndrome (AIDS). J Immunol 1986;137:2514-2521.
20. Lieberman J, Shankar P, Manjanath N, Andersson J. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 2001;98:1667-1677.
21. Autran B, Plata F, Guillon JM, Joly P, Mayaud C, Debré P. HIV-specific cytotoxic T lymphocytes directed against alveolar macrophages in HIV-infected patients. Res Virol 1990;141:131-136.
22. Twigg HL, Soliman DM, Day RB, Knox KS, Anderson RJ, Wilkes DS, Schnizlein-Bick CT. Lymphocytic alveolitis, bronchoalveolar lavage viral load, and outcome in human immunodeficiency virus infection. Am J Respir Crit Care Med 1999;159:1439-1444.
23. Twigg HL III, Spain BA, Soliman DM, Knox K, Sidner RA, Schnizlein-Bick C, Wilkes DS, Iwamoto GK. Production of interferon-gamma by lung lymphocytes in HIV-infected individuals. Am J Physiol 1999;276:L256-L262.
24. Agostini C, Zambello R, Facco M, Perin A, Piazza F, Siviero M, Basso U, Bortolin M, Trentin L, Semenzato G. CD8 T-cell infiltration in extravascular tissues of patients with human immunodeficiency virus infection: interleukin-15 upmodulates costimulatory pathways involved in the antigen-presenting cells-T-cell interaction. Blood 1999;93:1277-1286.
25. Agostini C, Poletti V, Zambello R, Trentin L, Siviero F, Spiga L, Gritti F, Semenzato G. Phenotypical and functional analysis of bronchoalveolar lavage lymphocytes in patients with HIV infection. Am Rev Respir Dis 1988;138:1609-1615.
26. Agostini C, Zambello R, Trentin L, Feruglio C, Masciarelli M, Siviero F, Poletti V, Spiga L, Gritti F, Semenzato G. Cytotoxic events taking place in the lung of patients with HIV-1 infection: evidence of an intrinsic defect of the major histocompatibility complex-unrestricted killing partially restored by the incubation with rIL-2. Am Rev Respir Dis 1990;142:516-522.
27. Poli G, Introna M, Zanaboni F, Peri G, Carbonari M, Aiuti F, Lazzarin A, Moroni M, Mantovani A. Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome. Clin Exp Immunol 1985;62:128-135.
28. Rankin JA, Walzer PD, Dwyer JM, Schrader CE, Enriquez RE, Merrill WW. Immunologic alterations in bronchoalveolar lavage fluid in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis 1983;128:189-194.
29. Twigg HL III, Spain BA, Soliman DM, Bowen LK, Heidler KM, Wilkes DS. Impaired IgG production in the lungs of HIV-infected individuals. Cell Immunol 1996;170:127-133.
30. Fahy RJ, Diaz PT, Hart J, Wewers MD. BAL and serum IgG levels in healthy asymptomatic HIV-infected patients. Chest 2001;119:196-203.
31. Musher DM, Watson DA, Nickeson D, Gyorkey F, Lahart C, Rossen RD. The effect of HIV infection on phagocytosis and killing of Staphylococcus aureus by human pulmonary alveolar macrophages. Am J Med 1990;299:158-163.
32. Reardon CC, Kim SJ, Wagner RP, Koziel H, Kornfeld H. Phagocytosis and growth inhibition of Cryptococcus neoformans by human alveolar macrophages: effects of HIV-1 infection. AIDS 1996;10:613-618.
33. Murray HW, Gellene RA, Libby DM, Rothermel CD, Rubin BY. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-γ. J Immunol 1985;135:2374-2377.
34. Koziel H, Eichbaum Q, Kruskal BA, Pinkston P, Rogers RA, Armstrong MY, Richards FF, Rose RM, Ezekowitz RA. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. J Clin Invest 1998;102:1332-1344.
35. Rich EA, Toossi Z, Fujiwara H, Hanigosky R, Lederman MM, Ellner JJ. Defective accessory function of monocytes in human immunodeficiency virus-related disease syndromes. J Lab Clin Med 1988;112:174-181.
36. Twigg HL III, Lipscomb MF, Yoffe B, Barbaro DJ, Weissler JC. Enhanced accessory cell function by alveolar macrophages from patients infected with the human immunodeficiency virus: potential role for depletion of CD4+ cells in the lung. Am J Respir Cell Mol Biol 1989;1:391-400.
37. Macatonia SE, Lau R, Patterson S, Pinching AJ, Knight SC. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 1990;71:38-45.
38. Spiegel H, Herbst H, Niedobitek G, Foss HD, Stein H. Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells. Am J Pathol 1992;140:15-22.
39. Wright SC, Jewett A, Mitsuyasu R, Bonavida B. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J Immunol 1988;141:99-104.
40. Ammann AJ, Palladino MA, Volberding P, Abrams D, Martin NL, Conant M. Tumor necrosis factor alpha and beta in acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Clin Immunol 1987;7:481-485.
41. Munis JR, Richman DD, Kornbluth RS. Human immunodeficiency virus-1 infection of macrophages in vitro neither induces tumor necrosis factor (TNF)/cachectin gene expression nor alters TNF/cachectin induction by lipopolysaccharide. J Clin Invest 1990;85:591-596.
42. Agostini C, Zambello R, Trentin L, Garbisa S, Di Cella PF, Bulian P, Onisto M, Poletti V, Spiga L, Raise E, et al. Alveolar macrophages from patients with AIDS and AIDS-related complex constitutively synthesize and release tumor necrosis factor alpha. Am Rev Respir Dis 1991;144:195-201.
43. Wewers MD, Diaz PT, Wewers ME, Lowe MP, Nagaraja HN, Clanton TL. Cigarette smoking in HIV infection induces a suppressive inflammatory environment in the lung. Am J Respir Crit Care Med 1998;158:1543-1549.
44. Lane BR, Markovitz DM, Woodford NL, Rochford R, Strieter RM, Coffey MJ. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J Immunol 1999;163:3653-3661.
45. Meddows-Taylor S, Pendle S, Tiemessen CT.Altered expression of CD88 and associated impairment of complement 5a-induced neutrophil responses in human immunodeficiency virus type 1-infected patients with and without pulmonary tuberculosis. J Infect Dis 2001;183:662-665.
46. Armbruster C, Krugluger W, Huber M, Stephan K. Immunoglobulin G Fc(gamma) receptor expression on polymorphonuclear cells in bronchoalveolar lavage fluid of HIV-infected and HIV-seronegative patients with bacterial pneumonia. Clin Chem Lab Med 2004;42:192-197.
47. Bandres JC, Trial J, Musher DM, Rossen RD. Increased phagocytosis and generation of reactive oxygen products by neutrophils and monocytes of men with stage 1 human immunodeficiency virus infections. J Infect Dis 1993;168:75-83.
48. Baldwin GC, Gasson JC, Quan SG, Fleischmann J, Weisbart R, Oette D, Mitsuyasu RT, Golde DW. Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients. Proc Natl Acad Sci USA 1988;85:2763-2766.
49. Roilides E,Walsh TJ, Pizzo PA, Rubin M. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 1991;163:579-583.
50. Lazzarin A, Uberti Foppa C, Galli M, Mantovani A, Poli G, Franzetti F, Novati R. Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome. Clin Exp Immunol 1986;65:105-111.